Rosiglitazone treatment of HIV-associated lipodystrophy syndrome:: impact on the bioavailability of antiretroviral compounds

被引:0
|
作者
Oette, M
Göbels, K
Kurowski, M
Kroidl, A
Feldt, T
Wettstein, M
Häussinger, D
机构
[1] Univ Dusseldorf, Gastroenterol Clin, D-4000 Dusseldorf, Germany
[2] Auguste Viktoria Krankenhaus, Berlin, Germany
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
115
引用
收藏
页码:L77 / L77
页数:1
相关论文
共 50 条
  • [31] Tesamorelin (Egrifta) for HIV-Associated Lipodystrophy
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2011, 53 (1363): : 34 - 35
  • [32] Effects of rosiglitazone on abnormal lipid kinetics in HIV-associated dyslipidemic lipodystrophy: a stable isotope study
    Sekhar, Rajagopal V.
    Patel, Sanjeet G.
    D'Amico, Susana
    Shi, Jianjian
    Balasubramanyam, Ashok
    Rehman, Khaleel
    Jahoor, Farook
    Visnegarwala, Fehmida
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (06): : 754 - 760
  • [33] Spotlight on Tesamorelin in HIV-Associated Lipodystrophy
    Dhillon, Sohita
    [J]. BIODRUGS, 2011, 25 (06) : 405 - 408
  • [34] Pharmacologic therapy for HIV-associated lipodystrophy
    Benavides, S
    Nahata, MC
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (03) : 448 - 457
  • [35] Leptin in congenital and HIV-associated lipodystrophy
    Tsoukas, Michael A.
    Farr, Olivia M.
    Mantzoros, Christos S.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (01): : 47 - 59
  • [36] HIV-associated lipodystrophy in South Africa: The impact on the patient and the impact on the plastic surgeon
    Zinn, Richard Joseph
    Serrurier, Charles
    Takuva, Simba
    Sanne, Ian
    Menezes, Colin Nigel
    [J]. JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2013, 66 (06): : 839 - 844
  • [37] The HIV-associated lipodystrophy syndrome: Research, results, yet more questions
    Gharakhanian, S
    [J]. AIDS, 2001, 15 (02) : 271 - 273
  • [38] Nandrolone decanoate; use in HIV-associated lipodystrophy syndrome: a pilot study
    Gold, J
    Batterham, M
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 1999, 10 (08) : 558 - 558
  • [39] Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy
    Vidal, Francesc
    Domingo, Pere
    Vilades, Consuelo
    Peraire, Joaquim
    Arnedo, Mireia
    Alcami, Jose
    Leal, Manuel
    Villarroya, Francesc
    Ma Gatell, Josep
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (11) : 1365 - 1382
  • [40] Recombinant Human Growth HormoneRationale for Use in the Treatment of HIV-Associated Lipodystrophy
    Stefano Benedini
    Ileana Terruzzi
    Adriano Lazzarin
    Livio Luzi
    [J]. BioDrugs, 2008, 22 : 101 - 112